Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Sudo Biosciences

Sudo Biosciences Announces Positive Phase 1 Results for Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
From Sudo Biosciences
Via Business Wire
Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
From Sudo Biosciences
Via Business Wire
Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
From Sudo Biosciences
Via Business Wire
Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic
From Sudo Biosciences
Via Business Wire
Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer
From Sudo Biosciences
Via Business Wire
Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics
From Sudo Biosciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.